Skip to main content
. 2014 Aug 13;8:1495–1505. doi: 10.2147/OPTH.S66637

Table 2.

Demographics for per-protocol population

BBOS 1.5% (N=70) Placebo (N=70) All subjects (N=140)
Age (years)
 Mean (SD) 38.3 (16.9) 37.1 (13.5) 37.7 (15.2)
 Median 39 39 39
 Min–max 11–73 13–65 11–73
P-valuea 0.644
Sex, N (%)
 Female 35 (50.0) 41 (58.6) 76 (54.3)
 Male 35 (50.0) 29 (41.4) 64 (45.7)
P-valueb 0.396
Ethnicity, N (%)
 Hispanic 3 (4.3) 4 (5.7) 7 (5.0)
 Non-hispanic 67 (95.7) 66 (94.3) 133 (95.0)
P-valueb 1.000
Race, N (%)
 African American 5 (7.2) 5 (7.2) 10 (7.1)
 American Indian or Alaska Native 0 (0.0) 0.0 (0) 0 (0.0)
 Asian 6 (8.6) 6 (8.6) 12 (8.6)
 Caucasian 57 (81.4) 59 (84.3) 116 (82.9)
 Other 2 (2.9) 0 (0.0) 2 (1.4)
P-valueb 0.753
Iris color,c n (%) (n=140) (n=140) (n=140)
 Blue 54 (38.6) 44 (31.4) 98 (35.0)
 Brown 58 (41.4) 70 (50.0) 128 (45.7)
 Green 12 (8.6) 12 (8.6) 24 (8.6)
 Hazel 16 (11.4) 12 (8.6) 28 (10.0)
 Other 0 (0.0) 2 (1.4) 2 (0.7)
P-valueb 0.347

Notes:

a

P-value calculated using two-sample t-test comparing BBOS 1.5% to placebo.

b

P-value calculated using Fisher’s exact test comparing BBOS 1.5% to placebo.

c

Values and percentages based upon number of eyes.

Abbreviations: BBOS, bepotastine besilate ophthalmic solution; min–max, minimum–maximum; N, number of subjects; n, number of eyes; SD, standard deviation.